corbuspharmaceuticals

$#corbuspharmaceuticals #StockTrade

The most interesting thing about Corbus Pharmaceuticals is that it has two potential growth drivers: experimental cancer treatments and a new obesity drug. Its value could change significantly if clinical trials produce strong results, but disappointing data could also cause a sharp share-price decline.